Navigation Links
Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
Date:10/25/2011

PITTSBURGH and POTTERS BAR, England, Oct. 25, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.K.-based subsidiary has launched Rivastigmine Capsules POM, 1.5 mg, 3 mg, 4.5 mg and 6 mg. This product is the generic version of Novartis' Exelon® Capsules, a treatment for dementia in people with Alzheimer's disease. Mylan is the first company to launch a generic Rivastigmine formulation in the U.K.

Mylan Chairman and CEO Robert J. Coury said: "This is the second recent first-to-market generic for Mylan's business in the U.K., following the company's successful launch of Modafinil tablets, 100 mg, the generic version of Cephalon's Provigil®, earlier this year. We are excited to be adding generic Rivastigmine to our strong portfolio of more than 350 products in the U.K., and delivering on our brand's commitment of providing high quality and affordable medicines to patients around the world."

Rivastigmine Capsules POM had U.K. sales of approximately pounds Sterling 7.9 million for the last 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylans Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist® Patents
2. Matrix Laboratories Completes Name Change to Mylan Laboratories
3. Mylan Announces Femcon® Fe Settlement Agreement
4. Mylan Announces Intention to Refinance Existing Secured Credit Facility
5. Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
6. Mylan Applauds Study Highlighting $931 Billion in Savings for U.S. Health Care System Due to Generic Drugs
7. Mylan Announces XELODA® Settlement and License Agreement
8. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
9. Mylan Launches Generic Version of Uroxatral® Tablets
10. Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
11. Mylan Launches First Generic Version of Entocort EC® Capsules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... SAN ANTONIO , Sept. 6, 2017  Robert ... as a Pinnacle Professional Member in recognition of his ... Dr. Szewc serves as a Nephrologist at the practice ... services, emergency medicine, kidney care and hypertension solutions. He ... over 20 years of career experience, as well as ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... 21, 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery Center is ... to announce that Plastic Surgeon Kiranjeet Gill has been awarded as one of the ... annual award that was started in 2003 to salute young achievers in Southwest Florida ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... SABRE is ... run from September 11 to the end of November. , The Chicago, Illinois, based ... their community and teach them about the ease of taking their personal safety into ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a ... public health departments have been awarded five-year accreditation status through the Public ... of being served by a PHAB-accredited health department now extend to more ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition ... try taking a more holistic approach and use natural alternatives for all house ... collection is certified USDA guaranteeing that, the new line of essential oils, are ...
Breaking Medicine News(10 mins):